Ex-Pharma CEO Sparks Controversy by Refusing to Testify on Skyrocketing Medicine Prices πŸ’Š

A former pharmaceutical executive, responsible for a 5,000% price hike on a vital drug, declines to testify at a congressional hearing, raising questions about transparency and drug pricing practices.

Ex-Pharma CEO Sparks Controversy by Refusing to Testify on Skyrocketing Medicine Prices πŸ’Š
euronews (in English)
47 views β€’ Feb 6, 2016
Ex-Pharma CEO Sparks Controversy by Refusing to Testify on Skyrocketing Medicine Prices πŸ’Š

About this video

A former pharmaceuticals chief, who hiked the price of a life-saving medicine by more than five thousand percent, has refused to testify in front of lawmakers. <br /><br /> Martin Shkreli, who used to head up Turing Pharmaceuticals, used a Fifth Amendment right against self-incrimination, as he was questioned by a House of Representatives committee. <br /><br /> β€œOn the advice of counsel, I invoke my Fifth Amendment privilege against incrimination and respectfully decline to answer your question,” said Shkreli.<br /><br /> After brushing off questions, the 32-year-old then tweeted that lawmakers were β€œimbeciles.”<br /><br /> Hard to accept that these imbeciles represent the people in our government.β€” Martin Shkreli (@MartinShkreli) February 4, 2016<br /><br /> Shkreli sparked outrage last year when he acquired Turing Pharmaceuticals and raised the price of the drug Daraprim to 750 US dollars (670 euros) a pill. <br /><br /> The medicine, used to treat a parasitic infection, once sold for one dollar (less than one euro) a pill and has been on t

Video Information

Views

47

Duration

0:52

Published

Feb 6, 2016

Related Trending Topics

LIVE TRENDS

Related trending topics. Click any trend to explore more videos.